CREATIVE REALITIES INC (CREX) Fundamental Analysis & Valuation

NASDAQ:CREX • US22530J3095

Current stock price

3.31 USD
-0.22 (-6.23%)
At close:
3.668 USD
+0.36 (+10.82%)
After Hours:

This CREX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CREX Profitability Analysis

1.1 Basic Checks

  • In the past year CREX was profitable.
  • CREX had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

  • CREX's Return On Assets of -14.93% is on the low side compared to the rest of the industry. CREX is outperformed by 65.22% of its industry peers.
  • With a Return On Equity value of -41.80%, CREX perfoms like the industry average, outperforming 42.39% of the companies in the same industry.
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • CREX has a Gross Margin of 43.13%. This is comparable to the rest of the industry: CREX outperforms 54.35% of its industry peers.
  • In the last couple of years the Gross Margin of CREX has grown nicely.
  • The Profit Margin and Operating Margin are not available for CREX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CREX Health Analysis

2.1 Basic Checks

  • CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CREX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CREX has been increased compared to 5 years ago.
  • The debt/assets ratio for CREX is higher compared to a year ago.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • CREX has an Altman-Z score of 0.32. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
  • CREX's Altman-Z score of 0.32 is on the low side compared to the rest of the industry. CREX is outperformed by 63.04% of its industry peers.
  • CREX has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CREX (1.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC8.19%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • CREX has a Current Ratio of 1.03. This is a normal value and indicates that CREX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.03, CREX is doing worse than 61.96% of the companies in the same industry.
  • CREX has a Quick Ratio of 1.03. This is a bad value and indicates that CREX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.77, CREX is not doing good in the industry: 68.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CREX Growth Analysis

3.1 Past

  • The earnings per share for CREX have decreased by 0.00% in the last year.
  • Looking at the last year, CREX shows a very negative growth in Revenue. The Revenue has decreased by -18.37% in the last year.
  • CREX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.98% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%

3.2 Future

  • Based on estimates for the next years, CREX will show a very strong growth in Earnings Per Share. The EPS will grow by 66.98% on average per year.
  • The Revenue is expected to grow by 32.68% on average over the next years. This is a very strong growth
EPS Next Y-91.64%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

3

4. CREX Valuation Analysis

4.1 Price/Earnings Ratio

  • CREX is valuated rather expensively with a Price/Earnings ratio of 23.64.
  • 70.65% of the companies in the same industry are more expensive than CREX, based on the Price/Earnings ratio.
  • CREX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.88.
  • The Price/Forward Earnings ratio is 12.73, which indicates a correct valuation of CREX.
  • 61.96% of the companies in the same industry are more expensive than CREX, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, CREX is valued a bit cheaper.
Industry RankSector Rank
PE 23.64
Fwd PE 12.73
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CREX is valued a bit more expensive than 61.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 216.22
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • CREX's earnings are expected to grow with 66.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.98%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CREX Dividend Analysis

5.1 Amount

  • CREX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CREX Fundamentals: All Metrics, Ratios and Statistics

CREATIVE REALITIES INC

NASDAQ:CREX (3/27/2026, 8:09:32 PM)

After market: 3.668 +0.36 (+10.82%)

3.31

-0.22 (-6.23%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-12
Earnings (Next)05-12
Inst Owners9.68%
Inst Owner Change10.7%
Ins Owners5.59%
Ins Owner Change0%
Market Cap77.78M
Revenue(TTM)44.32M
Net Income(TTM)-9.15M
Analysts84
Price Target8.29 (150.45%)
Short Float %0.55%
Short Ratio1.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.19%
Min EPS beat(2)-149.99%
Max EPS beat(2)-82.4%
EPS beat(4)1
Avg EPS beat(4)57.24%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-6.96%
Max Revenue beat(2)6.23%
Revenue beat(4)2
Avg Revenue beat(4)-2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-2.2%
Revenue beat(12)4
Avg Revenue beat(12)-4.14%
Revenue beat(16)4
Avg Revenue beat(16)-3.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 23.64
Fwd PE 12.73
P/S 1.75
P/FCF N/A
P/OCF N/A
P/B 3.55
P/tB N/A
EV/EBITDA 216.22
EPS(TTM)0.14
EY4.23%
EPS(NY)0.26
Fwd EY7.86%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.89
BVpS0.93
TBVpS-0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.71
Profitability
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.13%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score2
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 46.08
Cap/Depr 51.44%
Cap/Sales 5.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z 0.32
F-Score2
WACC8.19%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next Y-91.64%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A
EBIT growth 1Y-219.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.05%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-208.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.48%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 2 / 10 to CREX.


Can you provide the valuation status for CREATIVE REALITIES INC?

ChartMill assigns a valuation rating of 3 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Overvalued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


What are the PE and PB ratios of CREATIVE REALITIES INC (CREX) stock?

The Price/Earnings (PE) ratio for CREATIVE REALITIES INC (CREX) is 23.64 and the Price/Book (PB) ratio is 3.55.